German biotech firm BioNTech is behind one of the leading coronavirus vaccine candidates, having jointly developed it with US-based pharmaceutical company Pfizer. And according to its CEO, the 90% effective vaccine candidate is set to bring an end to the global pandemic. Speaking to UK newspaper The Guardian over Zoom, BioNTech CEO Ugur Sahin said he was optimistic of the vaccine's success. “If the question is whether we can stop this pandemic with this vaccine, then my answer is: yes, because I believe that even protection only from...
Full ArticleBioNTech CEO: Our coronavirus vaccine can end the pandemic
WorldNews
0 shares
1 views
You might like
Related news coverage
US stocks finish ahead in shortened session on Black Friday; Nasdaq closes at record high
Proactive Investors
1.30pm: US stocks end higher on Black Friday US stocks closed higher on the truncated Black Friday session, amid muted trade due to..
-
FTSE 100 enjoys delayed vaccine boost; AO World succumbs to profit-taking after stellar run
Proactive Investors
-
Wall Street mixed as vaccine optimism cheers traders, tech struggles
Proactive Investors
-
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Proactive Investors
-
US benchmarks start the week higher as more vaccine optimism cheers traders
Proactive Investors
Advertisement
More coverage
Moderna COVID-19 vaccine to cost govts $25-$37 per dose: CEO
Mid-Day
Governments seeking to purchase Moderna's potential COVID-19 vaccine may have to shell out $25 and $37 per dose, depending on the..
-
Moderna CEO Warns Vaccines Will Not End Coronavirus Pandemic: ‘We Need Public Health Measures’
Upworthy
-
Pfizer seeking emergency use of its COVID-19 vaccine in US
Mid-Day
-
US stocks close lower amid rising COVID-19 cases and economic-outlook fears
Proactive Investors
-
Wall Street mixed at midday as Fed and Treasury butt heads over lending programs
Proactive Investors